Clinical trial
Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)
NCT00004306 is registered in ClinicalTrials.gov with Office of Rare Diseases (ORD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)
- Lead sponsor
- Office of Rare Diseases (ORD)
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 1999
- Completion date
- March 31, 2009
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary ataxia